Skip to main content

Peer Review reports

From: Impact of molecular subtypes on the prediction of distant recurrence in estrogen receptor (ER) positive, human epidermal growth factor receptor 2 (HER2) negative breast cancer upon five years of endocrine therapy

Original Submission
20 Dec 2018 Submitted Original manuscript
22 Jan 2019 Reviewed Reviewer Report - Dedong Cao
18 Feb 2019 Reviewed Reviewer Report - James Driscoll
12 Mar 2019 Author responded Author comments - Mark Laible
Resubmission - Version 2
12 Mar 2019 Submitted Manuscript version 2
20 May 2019 Reviewed Reviewer Report - James Driscoll
26 May 2019 Reviewed Reviewer Report - Dedong Cao
14 Jun 2019 Author responded Author comments - Mark Laible
Resubmission - Version 3
14 Jun 2019 Submitted Manuscript version 3
26 Jun 2019 Author responded Author comments - Mark Laible
Resubmission - Version 4
26 Jun 2019 Submitted Manuscript version 4
Publishing
27 Jun 2019 Editorially accepted
15 Jul 2019 Article published 10.1186/s12885-019-5890-z

You can find further information about peer review here.

Back to article page